Xenon Pharmaceuticals Inc (XENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 6,829 | 0 | 311 | 1,803 | 15,577 |
| Gross Profit | 6,829 | N/A | 311 | 1,803 | 15,577 |
| Operating Expenses | 49,648 | 38,040 | 32,886 | 26,620 | 24,938 |
| Operating Income | -42,819 | -38,040 | -32,575 | -24,817 | -9,361 |
| Interest Expense | 1,434 | 1,394 | 0 | 0 | 0 |
| Other Income | 2,635 | 4,913 | 1,871 | 1,820 | -6,391 |
| Pre-tax Income | -41,618 | -34,521 | -30,704 | -22,997 | -15,752 |
| Income Tax | -23 | -24 | N/A | N/A | N/A |
| Net Income Continuous | -41,595 | -34,497 | -30,704 | -22,997 | -15,752 |
| Net Income | $-41,595 | $-34,497 | $-30,704 | $-22,997 | $-15,752 |
| EPS Basic Total Ops | -1.54 | -1.63 | -1.71 | -1.48 | -1.10 |
| EPS Basic Continuous Ops | -1.60 | -1.78 | -1.71 | -1.48 | -1.10 |
| EPS Diluted Total Ops | -1.54 | -1.63 | -1.72 | -1.48 | -1.10 |
| EPS Diluted Continuous Ops | -1.60 | -1.78 | -1.71 | -1.48 | -1.10 |
| EPS Diluted Before Non-Recurring Items | -1.54 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-41,865 | $-37,170 | $-31,915 | $-23,953 | $-8,323 |